10.25384/SAGE.6802394.v1 Messoud Ashina Messoud Ashina Stewart Tepper Stewart Tepper Jan Lewis Brandes Jan Lewis Brandes Uwe Reuter Uwe Reuter Guy Boudreau Guy Boudreau David Dolezil David Dolezil Sunfa Cheng Sunfa Cheng Feng Zhang Feng Zhang Robert Lenz Robert Lenz Jan Klatt Jan Klatt Daniel D Mikol Daniel D Mikol Supplementary table 1 -Supplemental material for Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study SAGE Journals 2018 Erenumab chronic migraine clinical trial of prophylactic migraine treatment prior preventive treatment failure prior prophylactic treatment failure 2018-07-08 12:00:00 Journal contribution https://sage.figshare.com/articles/journal_contribution/Supplementary_table_1_-Supplemental_material_for_Efficacy_and_safety_of_erenumab_AMG334_in_chronic_migraine_patients_with_prior_preventive_treatment_failure_A_subgroup_analysis_of_a_randomized_double-blind_placebo-controlled_study/6802394 <p>Supplemental material, Supplementary table 1 for Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study by Messoud Ashina, Stewart Tepper, Jan Lewis Brandes, Uwe Reuter, Guy Boudreau, David Dolezil, Sunfa Cheng, Feng Zhang, Robert Lenz, Jan Klatt and Daniel D Mikol in Cephalalgia</p>